NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
IARC Working Group on the Evaluation of Cancer-Preventive Interventions. Absence of excess body fatness. Lyon (FR): International Agency for Research on Cancer; 2021. (IARC Handbooks of Cancer Prevention, No. 16.)
- AKT
protein kinase B
- AL
ad libitum
- AML
acute myeloid leukaemia
- AMP
adenosine monophosphate
- AMPK
AMP-activated protein kinase
- AOM
azoxymethane
- ATP
adenosine triphosphate
- BIA
bioelectrical impedance analysis
- BMI
body mass index
- BOP
N-nitrosobis(2-oxopropyl)amine
- CDK
cyclin-dependent kinase
- cDNA
complementary DNA
- CDR
chronic dietary restriction
- CI
confidence interval
- CIMP
CpG island methylator phenotype
- CLL
chronic lymphocytic leukaemia
- CML
chronic myeloid leukaemia
- COX-2
cyclooxygenase-2
- CR
calorie restriction
- CRC
colorectal cancer
- CRP
C-reactive protein
- CT
computed tomography
- DEN
diethylnitrosamine
- DHEA
dehydroepiandrosterone
- DIO
diet-induced obesity
- DLBCL
diffuse large B-cell lymphoma
- DMBA
7,12-dimethylbenz[a]anthracene
- DR
dietary restriction
- DXA
dual-energy X-ray absorptiometry
- EDC
endocrine-disrupting chemical
- 8-epi-PGF2α
8-epi-prostaglandin F2α
- EPIC
European Prospective Investigation into Cancer and Nutrition
- ER
estrogen receptor
- F344
Fischer 344
- GIANT
Genetic Investigation of Anthropometric Traits
- GRS
genetic risk score
- GTG
gold thioglucose
- HBV
hepatitis B virus
- HCC
hepatocellular carcinoma
- HCV
hepatitis C virus
- HER2
human epidermal growth factor receptor 2
- HFD
high-fat diet
- HPV
human papillomavirus
- HR
hazard ratio
- HRT
hormone replacement therapy
- IARC
International Agency for Research on Cancer
- ICD
International Classification of Diseases
- IDR
intermittent dietary restriction
- IGF-1
insulin-like growth factor 1
- IGF-1R
IGF-1 receptor
- IGFBP
IGF binding protein
- IL
interleukin
- IWL
intentional weight loss
- LFD
low-fat diet
- MAPK
mitogen-activated protein kinase
- METs
metabolic equivalents
- MMTV
mouse mammary tumour virus
- MNU
N-methyl-N-nitrosourea
- MRI
magnetic resonance imaging
- MSI
microsatellite instability
- MSS
microsatellite-stable
- mTOR
mammalian target of rapamycin
- NAFLD
non-alcoholic fatty liver disease
- NAFPD
non-alcoholic fatty pancreatic disease
- NASH
non-alcoholic steatohepatitis
- NCDs
noncommunicable diseases
- NF-κB
nuclear factor kappa-light-chain-enhancer of activated B cells
- NHANES
National Health and Nutrition Examination Survey
- NHL
non-Hodgkin lymphoma
- NIH-AARP
National Institutes of Health–AARP Diet and Health Study
- NOS
not otherwise specified
- 25(OH)D
25-hydroxyvitamin D
- OR
odds ratio
- 8-oxo-dG
8-hydroxydeoxyguanosine
- PAI-1
plasminogen activator inhibitor-1
- PanIN
pancreatic intraepithelial neoplasia
- PCR
polymerase chain reaction
- PDAC
pancreatic ductal adenocarcinoma
- PI3K
phosphoinositide 3-kinase
- PIN
prostatic intraepithelial neoplasia
- PPAR
peroxisome proliferator-activated receptor
- PR
progesterone receptor
- PSA
prostate-specific antigen
- RCC
renal cell carcinoma
- RCT
randomized controlled trial
- ROS
reactive oxygen species
- RR
relative risk
- SASP
salicylazosulfapyridine
- SD
standard deviation
- SEER
Surveillance, Epidemiology, and End Results
- sGC
soluble guanylyl cyclase
- SHBG
sex hormone-binding globulin
- SHT
scopolamine hydrobromide trihydrate
- SLL
small lymphocytic lymphoma
- SNP
single nucleotide polymorphism
- STAT
signal transducer and activator of transcription
- TDR
total dietary restriction
- TGF
transforming growth factor
- TNF-α
tumour necrosis factor alpha
- TPA
12-O-tetradecanoylphorbol-13-acetate
- TRAMP
transgenic adenocarcinoma of the mouse prostate
- VEGF
vascular endothelial growth factor
- VO2max
maximal oxygen uptake
- WC
waist circumference
- WCRF
World Cancer Research Fund
- WHO
World Health Organization
- WHR
waist-to-hip ratio
- List of Abbreviations - Absence of excess body fatnessList of Abbreviations - Absence of excess body fatness
Your browsing activity is empty.
Activity recording is turned off.
See more...